Category: Immuno-oncology

Celgene, Google double down on Armo’s PhIII immuno-oncology drug with $67M round

by John Carroll — on August 29, 2017 09:31 AM EDT

Building up its I/O ops, CRISPR Therapeutics allies with Marcela Maus at Mass General

by John Carroll — on August 22, 2017 08:56 AM EDT

Arcus grabs US rights to a WuXi-built PD-1 as second wave of checkpoints builds

by John Carroll — on August 17, 2017 09:37 AM EDT
Updated: 09:41 AM

Looking for an oncology reboot, Sanofi, Regeneron shoot for a fast and flashy FDA OK of a promising new PD-1

by John Carroll — on August 1, 2017 08:44 AM EDT
Updated: 10:14 AM

CheckMate-227: Bristol-Myers Squibb has a MYSTIC-sized problem on its hands

by John Carroll — on July 28, 2017 08:36 AM EDT
Updated: 10:41 AM

PD-L1 checkpoint player Merck KGaA dives into next-gen work with F-star collaboration

by John Carroll — on June 4, 2017 02:41 PM EDT
Updated: 03:01 PM

Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker

by John Carroll — on May 23, 2017 05:25 PM EDT
Updated: May 24, 2017 08:52 AM

Incyte turns to Penn for a collaboration on next-gen cancer combos

by Arsalan Arif — on February 23, 2017 10:14 AM EDT
Updated: 10:26 AM

In a stunner, Merck leaps ahead of rivals with combo Keytruda/chemo attack on lung cancer

by John Carroll — on January 11, 2017 10:09 AM EDT
Updated: January 15, 2017 10:30 AM

Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be

by John Carroll — on October 25, 2016 06:33 AM EDT
Updated: October 26, 2016 09:59 PM

Bristol-Myers Squibb brings Opdivo to a joint immuno-oncology program with Nektar’s new T cell amplifier

by John Carroll — on September 27, 2016 07:03 AM EDT
Updated: 07:07 AM

$42M in, Flagship startups merge into one immuno-microbiome platform with multiple targets

by John Carroll — on July 12, 2016 03:11 AM EDT
Updated: 12:53 PM

Bristol-Myers’ nivolumab grabs its sixth breakthrough designation as new links to autoimmune diseases creep up

by Arsalan Arif — on June 27, 2016 10:25 AM EDT
Updated: 11:24 PM

Contact Endpoints News

Name

Email

Comment

You can also contact John Carroll, Editor at john@endpointsnews.com

← Go back

Yes, I'd like to subscribe No, thanks

I'm already a subscriber

Thank you for staying with us. It's great to have you on board!

Aww, shucks. Perhaps you can tell us what we could do to make you interested in subscribing?

Sure No

← Go back

Name

Email

Company

Sign in to Endpoints News

Email: Password:

I forgot my password Request a magic link

← Go back

Request a magic link

Enter your email below to get a Magic link which lets you sign in quickly without using a password.
Please note the Magic link is one-time use only and valid for only 24 hours. Email:

← Go back

Set a new password

We will send you a link, with which you will be able to set a new password.
Please note this link is one-time use only and valid for only 24 hours. Email: